Author:
Hanson Samuel M.,Forsyth Bruce,Wang Chun
Abstract
AbstractIrreversible electroporation (IRE) is used clinically as a focal therapy to ablate solid tumors. A critical disadvantage of IRE as a monotherapy for cancer is the inability of ablating large tumors, because the electric field strength required is often too high to be safe. Previous reports indicate that cells exposed to certain cationic small molecules and surfactants are more vulnerable to IRE at lower electric field strengths. However, low-molecular-weight IRE sensitizers may suffer from suboptimal bioavailability due to poor stability and a lack of control over spatiotemporal accumulation in the tumor tissue. Here, we show that a synthetic membranolytic polymer, poly(6-aminohexyl methacrylate) (PAHM), synergizes with IRE to achieve enhanced cancer cell killing. The enhanced efficacy of the combination therapy is attributed to PAHM-mediated sensitization of cancer cells to IRE and to the direct cell killing by PAHM through membrane lysis. We further demonstrate sustained release of PAHM from embolic beads over 1 week in physiological medium. Taken together, combining IRE and a synthetic macromolecular sensitizer with intrinsic membranolytic activity and sustained bioavailability may present new therapeutic opportunities for a wide range of solid tumors.
Funder
Boston Scientific Corporation
Publisher
Springer Science and Business Media LLC
Reference44 articles.
1. Jiang, C., Davalos, R. V. & Bischof, J. C. A review of basic to clinical studies of irreversible electroporation therapy. IEEE Trans. Biomed. Eng. 62, 4–20 (2015).
2. Gehl, J. Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol. Scand. 177, 437–447 (2003).
3. Davalos, R. V., Mir, L. M. & Rubinsky, B. Tissue ablation with irreversible electroporation. Ann. Biomed. Eng. 33, 223–231 (2005).
4. Deipolyi, A. R., Golberg, A., Yarmush, M. L., Arellano, R. S. & Oklu, R. Irreversible electroporation: evolution of a laboratory technique in interventional oncology. Diagn. Interv. Radiol. 20, 147–154 (2014).
5. Onik, G. & Rubinsky, B. Irreversible electroporation: first patient experience focal therapy of prostate cancer. In: Irreversible Electroporation. Series in Biomedical Engineering (ed. Rubinsky B.). (Springer, Berlin, Heidelberg, 2010). https://doi.org/10.1007/978-3-642-05420-4_10.
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献